A citation-based method for searching scientific literature

D M T Yu, L Slaitini, V Gysbers, A G M Riekhoff, T Kähne, H M Knott, I De Meester, C A Abbott, G W McCaughan, M D Gorrell. Scand J Immunol 2011
Times Cited: 44







List of co-cited articles
576 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV.
Anne-Marie Lambeir, Christine Durinx, Simon Scharpé, Ingrid De Meester. Crit Rev Clin Lab Sci 2003
628
45

Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome.
Daniela Lamers, Susanne Famulla, Nina Wronkowitz, Sonja Hartwig, Stefan Lehr, D Margriet Ouwens, Kristin Eckardt, Jean M Kaufman, Mikael Ryden, Stefan Müller,[...]. Diabetes 2011
384
36


On the origin of serum CD26 and its altered concentration in cancer patients.
Oscar J Cordero, Francisco J Salgado, Montserrat Nogueira. Cancer Immunol Immunother 2009
143
27


Molecular characterization of dipeptidyl peptidase activity in serum: soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides.
C Durinx, A M Lambeir, E Bosmans, J B Falmagne, R Berghmans, A Haemers, S Scharpé, I De Meester. Eur J Biochem 2000
212
25


DPP4 in Diabetes.
Diana Röhrborn, Nina Wronkowitz, Juergen Eckel. Front Immunol 2015
188
25

Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition.
Mark Kirby, Denise M T Yu, Steven O'Connor, Mark D Gorrell. Clin Sci (Lond) 2009
122
22


A potential role for dendritic cell/macrophage-expressing DPP4 in obesity-induced visceral inflammation.
Jixin Zhong, Xiaoquan Rao, Jeffrey Deiuliis, Zachary Braunstein, Vimal Narula, Jeffrey Hazey, Dean Mikami, Bradley Needleman, Abhay R Satoskar, Sanjay Rajagopalan. Diabetes 2013
115
22

Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26.
Guangwen Lu, Yawei Hu, Qihui Wang, Jianxun Qi, Feng Gao, Yan Li, Yanfang Zhang, Wei Zhang, Yuan Yuan, Jinku Bao,[...]. Nature 2013
407
22


The dipeptidyl peptidase IV family in cancer and cell biology.
Denise M T Yu, Tsun-Wen Yao, Sumaiya Chowdhury, Naveed A Nadvi, Brenna Osborne, W Bret Church, Geoffrey W McCaughan, Mark D Gorrell. FEBS J 2010
119
20


Dipeptidyl peptidase IV inhibition for the treatment of type 2 diabetes: potential importance of selectivity over dipeptidyl peptidases 8 and 9.
George R Lankas, Barbara Leiting, Ranabir Sinha Roy, George J Eiermann, Maria G Beconi, Tesfaye Biftu, Chi-Chung Chan, Scott Edmondson, William P Feeney, Huaibing He,[...]. Diabetes 2005
394
20

Long-term dipeptidyl-peptidase 4 inhibition reduces atherosclerosis and inflammation via effects on monocyte recruitment and chemotaxis.
Zubair Shah, Thomas Kampfrath, Jeffrey A Deiuliis, Jixin Zhong, Colleen Pineda, Zhekang Ying, Xiaohua Xu, Bo Lu, Susan Moffatt-Bruce, Rekha Durairaj,[...]. Circulation 2011
269
20

Sitagliptin exerts an antinflammatory action.
Antoine Makdissi, Husam Ghanim, Mehul Vora, Kelly Green, Sanaa Abuaysheh, Ajay Chaudhuri, Sandeep Dhindsa, Paresh Dandona. J Clin Endocrinol Metab 2012
174
20

Direct association of adenosine deaminase with a T cell activation antigen, CD26.
J Kameoka, T Tanaka, Y Nojima, S F Schlossman, C Morimoto. Science 1993
437
20

Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system.
C Klemann, L Wagner, M Stephan, S von Hörsten. Clin Exp Immunol 2016
187
20

CD26 up-regulates expression of CD86 on antigen-presenting cells by means of caveolin-1.
Kei Ohnuma, Tadanori Yamochi, Masahiko Uchiyama, Kunika Nishibashi, Noritada Yoshikawa, Noriaki Shimizu, Satoshi Iwata, Hirotoshi Tanaka, Nam H Dang, Chikao Morimoto. Proc Natl Acad Sci U S A 2004
89
18


Dipeptidyl peptidase inhibitors, an emerging drug class for inflammatory disease?
Roger Yazbeck, Gordon S Howarth, Catherine A Abbott. Trends Pharmacol Sci 2009
182
18

Diet-induced adipose tissue inflammation and liver steatosis are prevented by DPP-4 inhibition in diabetic mice.
Jun Shirakawa, Hideki Fujii, Kei Ohnuma, Koichiro Sato, Yuzuru Ito, Mitsuyo Kaji, Eri Sakamoto, Megumi Koganei, Hajime Sasaki, Yoji Nagashima,[...]. Diabetes 2011
185
18

Dipeptidyl peptidase IV: a cell surface peptidase involved in regulating T cell growth (review).
T Kahne, U Lendeckel, S Wrenger, K Neubert, S Ansorge, D Reinhold. Int J Mol Med 1999
114
18

Soluble DPP4 originates in part from bone marrow cells and not from the kidney.
Zhendi Wang, Christina Grigo, Julia Steinbeck, Stephan von Hörsten, Kerstin Amann, Christoph Daniel. Peptides 2014
40
20

Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26.
D Marguet, L Baggio, T Kobayashi, A M Bernard, M Pierres, P F Nielsen, U Ribel, T Watanabe, D J Drucker, N Wagtmann. Proc Natl Acad Sci U S A 2000
408
15

A novel consensus motif in fibronectin mediates dipeptidyl peptidase IV adhesion and metastasis.
Hung-Chi Cheng, Mossaad Abdel-Ghany, Bendicht U Pauli. J Biol Chem 2003
94
15

DPP-4 (CD26) inhibitor alogliptin inhibits TLR4-mediated ERK activation and ERK-dependent MMP-1 expression by U937 histiocytes.
Nga N Ta, Yanchun Li, Corinne A Schuyler, Maria F Lopes-Virella, Yan Huang. Atherosclerosis 2010
69
15

Cloning, expression and chromosomal localization of a novel human dipeptidyl peptidase (DPP) IV homolog, DPP8.
C A Abbott, D M Yu, E Woollatt, G R Sutherland, G W McCaughan, M D Gorrell. Eur J Biochem 2000
221
15

Revisiting an old acquaintance: CD26 and its molecular mechanisms in T cell function.
Kei Ohnuma, Nam H Dang, Chikao Morimoto. Trends Immunol 2008
170
15

CD26, let it cut or cut it down.
I De Meester, S Korom, J Van Damme, S Scharpé. Immunol Today 1999
381
15

Effects of short-term sitagliptin treatment on immune parameters in healthy individuals, a randomized placebo-controlled study.
J D Price, G Linder, W P Li, B Zimmermann, K I Rother, R Malek, M Alattar, K V Tarbell. Clin Exp Immunol 2013
22
31

CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse.
R Pacheco, J M Martinez-Navio, M Lejeune, N Climent, H Oliva, J M Gatell, T Gallart, J Mallol, C Lluis, R Franco. Proc Natl Acad Sci U S A 2005
174
15

Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance.
Stacey L Conarello, Zhihua Li, John Ronan, Ranabir Sinha Roy, Lan Zhu, Guoqiang Jiang, Franklin Liu, John Woods, Emanuel Zycband, David E Moller,[...]. Proc Natl Acad Sci U S A 2003
260
15

Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.
Benjamin M Scirica, Deepak L Bhatt, Eugene Braunwald, P Gabriel Steg, Jaime Davidson, Boaz Hirshberg, Peter Ohman, Robert Frederich, Stephen D Wiviott, Elaine B Hoffman,[...]. N Engl J Med 2013
15

Internalization of CD26 by mannose 6-phosphate/insulin-like growth factor II receptor contributes to T cell activation.
H Ikushima, Y Munakata, T Ishii, S Iwata, M Terashima, H Tanaka, S F Schlossman, C Morimoto. Proc Natl Acad Sci U S A 2000
86
15

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC.
V Stalin Raj, Huihui Mou, Saskia L Smits, Dick H W Dekkers, Marcel A Müller, Ronald Dijkman, Doreen Muth, Jeroen A A Demmers, Ali Zaki, Ron A M Fouchier,[...]. Nature 2013
15


CD26-mediated signaling for T cell activation occurs in lipid rafts through its association with CD45RO.
T Ishii, K Ohnuma, A Murakami, N Takasawa, S Kobayashi, N H Dang, S F Schlossman, C Morimoto. Proc Natl Acad Sci U S A 2001
128
13

Circulating CD26 is negatively associated with inflammation in human and experimental arthritis.
Nathalie Busso, Nicolai Wagtmann, Christian Herling, Veronique Chobaz-Péclat, Angelika Bischof-Delaloye, Alexander So, Eric Grouzmann. Am J Pathol 2005
158
13

Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1.
Kei Ohnuma, Masahiko Uchiyama, Tadanori Yamochi, Kunika Nishibashi, Osamu Hosono, Nozomu Takahashi, Shinichiro Kina, Hirotoshi Tanaka, Xin Lin, Nam H Dang,[...]. J Biol Chem 2007
86
13

Crystal structure of human dipeptidyl peptidase IV/CD26 in complex with a substrate analog.
Hanne B Rasmussen, Sven Branner, Finn C Wiberg, Nicolai Wagtmann. Nat Struct Biol 2003
295
13



The structure and function of CD26 in the T-cell immune response.
C Morimoto, S F Schlossman. Immunol Rev 1998
335
13

Coassociation of CD26 (dipeptidyl peptidase IV) with CD45 on the surface of human T lymphocytes.
Y Torimoto, N H Dang, E Vivier, T Tanaka, S F Schlossman, C Morimoto. J Immunol 1991
217
13

The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha.
Gian Paolo Fadini, Elisa Boscaro, Mattia Albiero, Lisa Menegazzo, Vera Frison, Saula de Kreutzenberg, Carlo Agostini, Antonio Tiengo, Angelo Avogaro. Diabetes Care 2010
254
13

Soluble CD26/dipeptidyl peptidase IV induces T cell proliferation through CD86 up-regulation on APCs.
K Ohnuma, Y Munakata, T Ishii, S Iwata, S Kobayashi, O Hosono, H Kawasaki, N H Dang, C Morimoto. J Immunol 2001
57
13



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.